Evaluation of the Efficacy of Optometric Rehabilitation on Visual Cognitive Deficits in Children
NCT ID: NCT02061501
Last Updated: 2014-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
70 participants
INTERVENTIONAL
2014-06-30
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We aim to evaluate the efficacy of such therapy by a comparative study between two groups of children aged between 5 and 12 after 6 months of rehabilitation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Observational Study of Optical Correction for Strabismic Amblyopia in Children 3 to <7 Years Old
NCT00669539
Effect of Binocular Treatment Using a Dichoptic Reading Application in Children With Convergence Insufficiency.
NCT06465615
Effectiveness of Virtual Reality Training in Amblyopia
NCT05732467
Exploring Perceptual Learning in Blurred Gabor Discrimination for Low-Myopic Children
NCT07107646
Effect of Vision Therapy in Myopic Children With Poor Accommodative Response
NCT03006601
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Speech therapy
Speech therapy (30 min per week) alone for the 6 first months. Then speech therapy (30 min per week) and optometric therapy (30 min per week) for the 6 last months.
Optometric therapy during 6 months
Optometric therapy during 6 months, once a week
Speech therapy and optometric therapy
Speech therapy (30 min per week) and optometric therapy (30 min per week) for 12 months.
Optometric therapy during 12 months
Optometric therapy once a week, during 12 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Optometric therapy during 6 months
Optometric therapy during 6 months, once a week
Optometric therapy during 12 months
Optometric therapy once a week, during 12 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* normal intelligence
Exclusion Criteria
* mental deficiency
* visual acuity deficit
5 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CRTLA - Hôpital de Hautepierre- CHRU Strasbourg
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5542
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.